[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Ethics::
peer-review::
Indexing::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Journal DOI

AWT IMAGE

..
Copyright Policy
This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 
This Journal is licensed under a Creative Commons Attribution-NonCommercial 4.0
..
:: Volume 12, Issue 4 (10-2010) ::
J Babol Univ Med Sci. 2010; Volume 12 Back to browse issues page
Comparison of Flutamide and Metformin in Overweight-Obese Women with Polycystic Ovary Syndrome Following a Hypocaloric Dieting
S Esmaeilzadeh * , L Ghorbani , M Sharbatdaran , A Bijani , P Sajadi
Abstract:   (11353 Views)
BACKGROUND AND OBJECTIVE: Polycystic ovary syndrome is one of the most common items in endocrine diseases and involved patients are at the risk of diabetes and atherosclerosis and cardiovascular disease. The most common clinical features of PCOS are insulin resistance, hyperandrogenemia, non ovulation and infertility. Since obesity is the most common cause of insulin resistance and hyperandrogenemia, so this study was designed to evaluate the effects of weight reduction and treatment with metformin and flutamide on insulin resistance indices and hyperandrogenism and lipid serum in overweight-obese PCOS patients.
METHODS: This double blind clinical trial study was performed on 40 overweight-obese women with PCOS. After a one month diet, according to a control trial double blind design, the patients were randomly allocated to treatment with placebo, metformin (500mg/TDS) and flutamide (250 mg/BID) for the following 6 months while continuing hypocaloric dieting. At baseline and at the end of the study anthropometric parameters, hirsutism and menses, sex hormones, SHBG, lipid and insulin sensitivity determinations were measured and compared in two groups.
FINDINGS: Metformin (12.2±6.07 kg) has a significant effect in decreasing body weight (p=0.000), BMI (p=0.000), waist circumference (p=0.000) and hip circumference (p=0.000) and hirsutism (p=0.000), total testosterone (p=0.032). Flutamide (6.5±5.1 kg) has effectively decreased body weight (p=0.000), BMI (p=0.000), waist circumference (p=0.000) and waist/hip circumference (p=0.005) and hirsutism (p=0.000), total testosterone
(p =0.024), cholesterol (p=0.011) and LDL levels (p=0.013).
CONCLUSION: The results of this study showed that safe drugs such as metformin and flutamide reduced in anthropometric indices and hirsutism. Metformin has been more effective in reducing weight, BMI, waist and hip circumference rather than flutamide.
Keywords: Polycystic ovary syndrome, Metformin, Flutamide, hypocaloric diet, Hirsutism
Full-Text [PDF 210 kb]   (1524 Downloads)    
Type of Study: Research | Subject: Biochemical
Accepted: 2014/06/6 | Published: 2014/06/6


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Esmaeilzadeh S, Ghorbani L, Sharbatdaran M, Bijani A, Sajadi P. Comparison of Flutamide and Metformin in Overweight-Obese Women with Polycystic Ovary Syndrome Following a Hypocaloric Dieting. J Babol Univ Med Sci 2010; 12 (4) :7-13
URL: http://jbums.org/article-1-3661-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 12, Issue 4 (10-2010) Back to browse issues page
مجله علمی دانشگاه علوم پزشکی بابل Journal of Babol University of Medical Sciences

The Journal of Babol University of Medical Sciences is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Persian site map - English site map - Created in 0.06 seconds with 43 queries by YEKTAWEB 4645